483
ICON PLCFDA 483 - ICON PLC - June 13, 2025
Discuss this record with AI
Record Details
An FDA inspection of ICON PLC's bioanalytical facility in Lenexa, KS, revealed three observations. The firm was cited for using calibration standards and QC samples beyond their established stability period. Additionally, issues were noted regarding the reporting of reinjected samples due to instrument errors and the failure to report reprocessed samples.
Open in Dashboard
ID · e630c682-4dfc-4830-9d1d-0a466fb3e90a